Join the HIV Infection group to help and get support from people like you.
HIV Infection News (Page 3)
Related terms: Acquired Immune Deficiency Syndrome, Acquired Immunodeficiency Syndrome (AIDS), Acute HIV Infection, Acute Retroviral Syndrome, AIDS, AIDS-Related Complex, Chronic Symptomatic HIV Infection, HIV Infection, Acute, HIV Seroconversion Syndrome, Human Immunodeficiency Virus Infection, Primary HIV Infection, HIV, ARC, Acquired Immunodeficiency Syndrome, HIV/AIDS
Court Ruling Could Bring Higher Patient Costs for PrEP, and More HIV Infections
TUESDAY, Jan. 9, 2024 – HIV pre-exposure prophylaxis (PrEP) is a lifeline for Americans, many of them gay men, who are at high risk of contracting the virus that causes AIDS. But a case that is...
Doxycycline Postexposure Prophylaxis Does Not Avert STIs in Women
THURSDAY, Dec. 21, 2023 – For Kenyan women receiving preexposure prophylaxis against HIV, the incidence of sexually transmitted infections (STIs) does not differ for those receiving doxycycline...
2014 to 2021 Saw Increase in HIV Testing, PrEP in Transgender Persons
MONDAY, Dec. 18, 2023 – From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published...
2014 to 2021 Saw Increase in HIV Testing, PrEP in Transgender Persons
MONDAY, Dec. 18, 2023 – From 2014 to 2021, there was an increase in the number of transgender persons with an HIV test and who received preexposure prophylaxis (PrEP), according to a study published...
Theratechnologies Announces FDA Approval of Trogarzo 90-Second Intravenous (IV) Push Loading Dose
Updated label means new Trogarzo® patients no longer require initiation of treatment by 30-minute infusion Complete IV push method enables easier and more convenient administration of Trogarzo® for h...
Virological Suppression Sustained With Very Early ART in Neonates With HIV-1
TUESDAY, Dec. 12, 2023 – For neonates with in utero HIV-1, very early antiretroviral therapy (ART) can achieve sustained virological suppression, according to a study published online Dec. 4 in The...
Swift Use of Antiretrovirals in Infected Newborns Can Banish HIV
MONDAY, Dec. 11, 2023 – When an HIV-infected child known as the 'Mississippi baby' was given powerful antiretroviral drugs within hours of birth in 2013 and then appeared to be rid of HIV, people...
Mortality Increased for Infants, Under 5s With HIV Receiving Antiretrovirals
THURSDAY, Nov. 30, 2023 – More infants and children aged younger than 5 years with HIV receiving antiretroviral therapy (ART) die compared with those aged 5 years and older receiving ART, according...
COVID Pandemic Set Back U.S. Efforts to Fight HIV
FRIDAY, Nov. 17, 2023 – Here's another casualty of the pandemic: Gains made against another scourge, HIV. Progress made in fighting HIV/AIDS across all segments of society was eroded during the...
2018 to 2021 Saw Increase in HIV PrEP Provision for Adolescents
MONDAY, Oct. 30, 2023 – From 2018 to 2021, there was an increase in HIV preexposure prophylaxis (PrEP) provision among adolescents, especially among male and older adolescents, according to a study...
Daily Oral PrEP Has Highest Preference Ranking Among Young Men
THURSDAY, Oct. 12, 2023 – Daily oral preexposure prophylaxis (PrEP) has the highest preference ranking among young men who have sex with men, according to a study recently published in the Journal...
Despite New Long-Term Options, People Still Prefer Daily PrEP Pill to Prevent HIV
TUESDAY, Oct. 3, 2023 – New ways to deliver drugs that prevent infection with HIV are out there, but many people still prefer the standard daily PrEP pill, a new study shows. “The oral pill is very e...
Beauty Salon-Based Intervention Builds Knowledge of PrEP in Black Women
THURSDAY, Sept. 14, 2023 – A beauty salon-based intervention improves awareness of and trust in preexposure prophylaxis (PrEP) against HIV among Black cisgender women, according to a study published...
Hypertension, Statin Use Increased for Individuals Using TAF for PrEP
THURSDAY, Sept. 14, 2023 – For individuals taking preexposure prophylaxis (PrEP) for preventing HIV infection, tenofovir alafenamide fumarate (TAF) use is associated with higher incident...
USPSTF Reaffirms Recommendation of PrEP for Those at Increased HIV Risk
TUESDAY, Aug. 22, 2023 – The U.S. Preventive Services Task Force (USPSTF) recommends prescription of preexposure prophylaxis (PrEP) with effective antiretroviral therapy for individuals at increased...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Pre-Exposure Prophylaxis, Viral Infection
Related drug support groups
Biktarvy, bictegravir / emtricitabine / tenofovir alafenamide, Genvoya, Triumeq